| Pfizer AG - Dalacin C 150 mg, Hartkapseln | | 35438 | | 04 | | Dalacin C 150 mg | | Hartkapseln | | J01FF01 | | Clindamycin | | 22.08.2006 | | |
| | Composition | | clindamycinum 150 mg ut clindamycini hydrochloridum, maydis amylum, talcum, magnesii stearas, lactosum monohydricum max. 224.13 mg, Kapselhülle: gelatina, E 171, Drucktinte: lacca, E 172 (nigrum), propylenglycolum, ammoniae solutio concentrata, kalii hydroxidum, pro capsula. | | Packungsbestandteile | | Capsules | | | | | Active Agent | Dose |
|---|
| Clindamycin | 150 mg |
| | BAG: Active Agent | Dose |
|---|
| Clindamycin | 150 mg |
| | | | Inactive agents | Dose | additional_information |
|---|
| | | | | | | | | | | color. | | | | color. | | Gelatina | | Kapselhülle | | | | | | | | Drucktinte | | Lactose Monohydrate | 224.13 mg | | | | | | | | | | | | | | | Propylenglycol | | | | Talcum | | |
| |
| | Package number | Package Size | EFP | CP | Category | SL | Out of trade (MedRef) |
|---|
| 068 | 16 Capsule(s) | 8.29 | 18.20 | A | SL | No |
|
|
